Please login to the form below

Not currently logged in
Email:
Password:

Cambridge, UK

This page shows the latest Cambridge, UK news and features for those working in and with pharma, biotech and healthcare.

Sanofi gains access to antibody tech with Kymab acquisition

Sanofi gains access to antibody tech with Kymab acquisition

Sanofi has made a $1.45bn play for Cambridge, UK-based Kymab, extending its reach into immunotherapy and immunology.

Latest news

More from news
Approximately 2 fully matching, plus 68 partially matching documents found.

Latest Intelligence

  • AI and accelerated computing ring in new era for healthcare AI and accelerated computing ring in new era for healthcare

    And pharmaceutical companies, including GlaxoSmithKline, and major healthcare systems, like the UK’s National Health Service (NHS), will harness technologies like the Cambridge-1 supercomputer – the UK’s fastest AI supercomputer –

  • AstraZeneca’s focus on diagnosing and managing chronic kidney disease AstraZeneca’s focus on diagnosing and managing chronic kidney disease

    AstraZeneca's R&D centre in Cambridge, UK. Moderate to severe chronic kidney disease (CKD) is an under-recognised public health emergency.

  • A snapshot of Healx A snapshot of Healx

    Healx is based in Cambridge, UK, a key European biotech hub, and was founded in 2014 by Dr Tim Guilliams, a biochemical engineer and founder of the Cambridge Rare Disease Network, ... That said, we share the concerns of a number of UK industry bodies and

  • A snapshot of Microbiotica A snapshot of Microbiotica

    Cambridge, UK-based Microbiotica is part of a new wave of pioneering firms focused on developing novel therapeutics based on the microbiome – the bacteria which live in the human body and ... of CMOs in the world who can do this work, with none in the

  • A snapshot of Crescendo Biologics A snapshot of Crescendo Biologics

    The company is based in Cambridge, UK, which is renowned for its antibody and biologics research and expertise, making it a prime location for Crescendo’s work. ... Cambridge, UK is probably the leading antibody and biologics development location in

More from intelligence
Approximately 2 fully matching, plus 15 partially matching documents found.

Latest appointments

  • F-star hires ex-BMS immuno-oncology leader

    New CMO to oversee development of lead candidate. UK biotech F-star has appointed Louis Kayitalire, MD, as its new Chief Medical Officer (CMO), wooing him from a senior role in ... F-star says this newly created management position will be crucial

  • New faces at BioStrata, P\S\L Group and FCB Health New faces at BioStrata, P\S\L Group and FCB Health

    All five new hires will be based out of the company’s UK headquarters in Cambridge. ... Rachael Young, inbound account executive and Sam Willstead, PR account executive, are both recent science graduates from the University of Cambridge and the

  • BMS appoints new commercial leader, Davies joins Eisai and more BMS appoints new commercial leader, Davies joins Eisai and more

    Congenica poaches AZ’s business performance director. Currently director of business performance at AstraZeneca, Wendy Britten (pictured) has decided to join Cambridge, UK-based Cogenica, a clinical genomics interpretation software provider.

  • BioStrata strengthens team with two new hires BioStrata strengthens team with two new hires

    James Reeve and Kat Steer join the marketing agency. Cambridge, UK-based life science agency has expanded their PR, social strategy and digital services team with the addition of two senior

  • Constellation Pharmaceuticals strengthens management team Constellation Pharmaceuticals strengthens management team

    Appointments include Adrian Senderowicz as chief medical officer. Cambridge, UK-based Constellation Pharmaceuticals has appointed Adrian Senderowicz as its senior vice president and chief medical officer.

More from appointments
Approximately 0 fully matching, plus 29 partially matching documents found.

Latest from PMHub

  • MAKING THE FIRST YEAR MATTER

    Since the launch of its new proposition in January 2021 following the merger of Pegasus, Ashfield Digital and Creative and Cambridge Biomarketing, the UK Mind Matter team, led by Corrina Safeio, ... Ian and Kesha join the UK Mind Matter leadership team

  • Ashfield Healthcare Communications rebrands as Ashfield Health

    Ashfield Digital and Creative (UK), Cambridge BioMarketing (US) and Pegasus (UK) merge to form Mind Matter, a new global, data-driven creative communications agency. ... Formed through the merging of three successful Ashfield Health agencies – US-based

  • Zyme Communications

    Address:. Stirling House, Cambridge Innovation Park. Denny End Road, Waterbeach, Cambridge.

  • Moving away from pharma’s paternalistic approach

    12 September 2018, Cambridge, UK—The pharmaceutical industry has achieved great success in delivering innovative medicines, but life science companies must become ever more consumer-centric if they are to realise ... Any profits generated from book

  • Cogentia

    Cogentia is a market access and health economic consulting company based in Cambridge, UK. ... Address:. 16-20 Regent Street. Cambridge. CB2 1DB. United Kingdom.

More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
certain health

Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....